1. Home
  2. TDW vs SYRE Comparison

TDW vs SYRE Comparison

Compare TDW & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tidewater Inc.

TDW

Tidewater Inc.

HOLD

Current Price

$52.92

Market Cap

2.8B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$31.02

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDW
SYRE
Founded
1956
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
TDW
SYRE
Price
$52.92
$31.02
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$67.50
$56.50
AVG Volume (30 Days)
623.9K
850.2K
Earning Date
02-26-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.97
N/A
Revenue
$1,361,073,000.00
N/A
Revenue This Year
$0.76
N/A
Revenue Next Year
$0.81
N/A
P/E Ratio
$17.95
N/A
Revenue Growth
4.42
N/A
52 Week Low
$31.17
$10.91
52 Week High
$64.07
$35.31

Technical Indicators

Market Signals
Indicator
TDW
SYRE
Relative Strength Index (RSI) 50.09 49.54
Support Level $49.92 $28.00
Resistance Level $55.07 $33.31
Average True Range (ATR) 1.75 1.54
MACD 0.14 -0.68
Stochastic Oscillator 61.12 44.15

Price Performance

Historical Comparison
TDW
SYRE

About TDW Tidewater Inc.

Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: